$24.44-0.79|(-3.13%)
52W H: 31.73552W L: 12.895Beta: 1.05

About Arcus Biosciences Inc

Frequently Asked Questions

What is the 52-week range for RCUS?

The 52-week high is $31.735 and the 52-week low is $12.895.

What is the P/E ratio for RCUS?

The P/E ratio data is currently unavailable.

What is the dividend yield for RCUS?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -89.54%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -393.16%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 4.67.

Analyst Recommendation Trends

Wall Street analyst consensus for RCUS over the last few months:

2026-09-01
Buy: 10
S.Buy: 5
Hold: 4
Sell: 0
2026-08-01
Buy: 10
S.Buy: 5
Hold: 4
Sell: 0
2026-07-01
Buy: 10
S.Buy: 5
Hold: 4
Sell: 0
2026-06-01
Buy: 9
S.Buy: 5
Hold: 4
Sell: 0

Latest RCUS News

Wedbush Reiterates Outperform on Arcus Biosciences, Maintains $43 Price Target

Wedbush analyst Robert Driscoll reiterates Arcus Biosciences (NYSE:RCUS) with a Outperform and maintains $43 price target.

Benzinga9/30/2026

Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy

HAYWARD, Calif., September 22, 2026--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and inflammatory diseases, announced today that it will host an in-person investor event with a live webcast on Tuesday, October 20, 2026, beginning at 8:30 AM ET, in New York City.

Yahoo9/22/2026

TD Cowen Initiates Coverage On Arcus Biosciences with Buy Rating

TD Cowen analyst Tara Bancroft initiates coverage on Arcus Biosciences (NYSE:RCUS) with a Buy rating.

Benzinga9/16/2026

Arcus Biosciences, Inc. (RCUS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Arcus Biosciences, Inc. (RCUS) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 12:20 PM EDTCompany ParticipantsTerry Rosen -...

SeekingAlpha9/15/2026

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 44.6% to $2.4 during Monday's pre-market session. The company's market cap stands at $1.1 million. Definium Therapeutics (NASDAQ:DFTX)

Benzinga9/14/2026

Arcus Biosciences Announces New Employment Inducement Grants

HAYWARD, Calif., September 09, 2026--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted one new employee options to purchase a total of 26,350 shares of the Company’s common stock at an exercise price per share of $29.06, which was t

Yahoo9/9/2026

Arcus Biosciences, Inc. (RCUS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Arcus Biosciences, Inc. (RCUS) Citigroup's Biopharma Back to School Summit 2026 September 9, 2026 10:40 AM EDTCompany ParticipantsRobert Goeltz - Principal...

SeekingAlpha9/9/2026

Truist Securities Reiterates Buy on Arcus Biosciences, Raises Price Target to $40

Truist Securities analyst Supawat Thongthip reiterates Arcus Biosciences (NYSE:RCUS) with a Buy and raises the price target from $35 to $40.

Benzinga9/8/2026

Related Stocks (Peers)

Companies operating in similar sectors to RCUS:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-08-21Azoy Alexander-2,827--
2026-08-21Azoy Alexander-2,827$30$84,810
2026-08-21Azoy Alexander+2,827$15.44$43,649
2026-07-10Jaen Juan C.-268$29.397$7,878
2026-07-10Jaen Juan C.-19,799$28.608$566,410
2026-07-09Jaen Juan C.-48,502$30.053$1,457,631
2026-06-24Jaen Juan C.-6,431$29.6595$190,740
2026-06-23Jaen Juan C.-1,697$28.0612$47,620
2026-06-23Jaen Juan C.-14,067$27.6875$389,480
2026-06-22Jaen Juan C.-9,236$27.0313$249,661
2026-06-11Tang Carolyn C.-34,090$2.574$87,748
2026-06-11Tang Carolyn C.+34,090$2.574$87,748
2026-06-11Ribas Antoni+16,900--
2026-06-11Ribas Antoni+5,700--
2026-06-11Lambert Nicole+16,900--
2026-06-11Lambert Nicole+5,700--
2026-06-11Lacey David L.+16,900--
2026-06-11Lacey David L.+5,700--
2026-06-11Machado Patrick+16,900--
2026-06-11Machado Patrick+5,700--
2026-06-11KANEKO YASUNORI+16,900--
2026-06-11KANEKO YASUNORI+5,700--
2026-06-11FALBERG KATHRYN E+16,900--
2026-06-11FALBERG KATHRYN E+5,700--
2026-06-11PERLMAN ANDREW J+16,900--
2026-06-11PERLMAN ANDREW J+5,700--
2026-06-01Azoy Alexander-2,562$25.7704$66,024
2026-05-11Goeltz II Robert C.-7,763$25.63$198,966
2026-01-23Markus Richard+96,000--
2026-01-23Markus Richard+24,000--
2026-01-23Tang Carolyn C.+96,000--
2026-01-23Tang Carolyn C.+24,000--
2026-01-23Azoy Alexander+14,050--
2026-01-23Azoy Alexander+21,050--
2026-01-23Jarrett Jennifer+126,000--
2026-01-23Jarrett Jennifer+31,000--
2026-01-23Goeltz II Robert C.+96,000--
2026-01-23Goeltz II Robert C.+24,000--
2026-01-23Jaen Juan C.+126,000--
2026-01-23Jaen Juan C.+31,000--
2026-01-23ROSEN TERRY J+315,000--
2026-01-23ROSEN TERRY J+79,000--
2026-01-08ROSEN TERRY J-35,000--
2026-01-05Jaen Juan C.-100$23.2$2,320
2026-01-05Jaen Juan C.-2,053$22.34$45,864
2026-01-05Jaen Juan C.-29,670$21.34$633,158
2025-12-31Goeltz II Robert C.-6,552$23.38$153,186
2025-12-30ROSEN TERRY J-2,400--
2025-12-18Azoy Alexander-4,343$22.2458$96,614
2025-12-17Markus Richard-4,494$22.1595$99,585
2025-12-17Tang Carolyn C.-6,810$22.1595$150,906
2025-12-17Azoy Alexander-2,113$22.1595$46,823
2025-12-17Jarrett Jennifer-9,983$22.1595$221,218
2025-12-17Goeltz II Robert C.-5,960$22.1595$132,071
2025-12-17Jaen Juan C.-9,983$22.1595$221,218
2025-12-17ROSEN TERRY J-25,744$22.1595$570,474
2025-12-16Ribas Antoni-5,050--
2025-12-16Markus Richard-5,052$21.8843$110,559
2025-12-16Tang Carolyn C.-7,658$21.8843$167,590
2025-12-16Azoy Alexander-2,376$21.8843$51,997
2025-12-16Jarrett Jennifer-11,225$21.8843$245,651
2025-12-16Goeltz II Robert C.-6,702$21.8843$146,669
2025-12-16Jaen Juan C.-11,225$21.8843$245,651
2025-12-16ROSEN TERRY J-28,947$21.8843$633,485
2025-12-04Jaen Juan C.-82,997$24.7069$2,050,599
2025-11-26Azoy Alexander-1,900--
2025-11-26Azoy Alexander-1,900$26$49,400
2025-11-26Azoy Alexander+1,900$13.33$25,327
2025-11-26Goeltz II Robert C.-5,000$25$125,000
2025-11-18Jaen Juan C.-5,050$19.75$99,738
2025-11-17Jaen Juan C.-7,836$20.713$162,307
2025-11-17Jaen Juan C.-37,114$20.2274$750,720
2025-11-07Jarrett Jennifer-50,291$1.2276$61,737
2025-11-07Jarrett Jennifer-50,291$18.9709$954,066
2025-11-07Jarrett Jennifer+50,291$1.2276$61,737
2025-10-30Jaen Juan C.-4,314$20.3175$87,650
2025-10-29Jaen Juan C.-800$22.0441$17,635
2025-10-29Jaen Juan C.-29,365$21.5279$632,167
2025-10-29Jaen Juan C.-47,675$20.4894$976,832
2025-10-28Jaen Juan C.-19,019$20.1874$383,944
2025-10-28Goeltz II Robert C.-5,000$20$100,000
2025-10-08Jarrett Jennifer-37,792--
2025-10-08Jarrett Jennifer-37,792$15.0458$568,611
2025-10-08Jarrett Jennifer+37,792$1.2276$46,393
2025-10-06Jarrett Jennifer-12,500--
2025-10-06Jarrett Jennifer-12,500$14.5441$181,801
2025-10-06Jarrett Jennifer+12,500$1.2276$15,345